Christopher Dupont
About Christopher Dupont
Christopher Dupont serves as the Associate Director and Clinical Translational Lead at Adaptimmune in Cambridge, Massachusetts, where he has worked since 2023. He has a robust background in clinical biomarker projects and holds a PhD in Cell/Cellular and Molecular Biology from the University of Pennsylvania.
Work at Adaptimmune
Christopher Dupont serves as the Associate Director, Clinical Translational Lead at Adaptimmune, a role he has held since 2023. He is based in Cambridge, Massachusetts. In this position, he is responsible for overseeing clinical translational projects, focusing on the development and implementation of strategies that enhance clinical biomarker research.
Education and Expertise
Christopher Dupont earned his Doctor of Philosophy (PhD) in Cell/Cellular and Molecular Biology from the University of Pennsylvania, where he studied from 2007 to 2014. He also holds a Bachelor of Science (B.S.) in Biology/Biological Sciences from SUNY Geneseo, completed from 2003 to 2007. His educational background provides a strong foundation for his expertise in clinical biomarker projects and assay development.
Background
Christopher Dupont has a diverse professional background in the biotechnology and pharmaceutical sectors. He has worked in various capacities, including roles as a Scientist II and Principal Scientist at Agenus and Oncorus, respectively. His experience spans from 2005 as an Undergraduate Researcher at SUNY Geneseo to his current position at Adaptimmune, showcasing a progressive career in scientific research and clinical development.
Achievements in Assay Development
Throughout his career, Christopher Dupont has developed and validated a wide range of assays, including pharmacokinetics (PK), immunogenicity, quantitative PCR (qPCR), liquid chromatography-mass spectrometry (LCMS), immunohistochemistry (IHC), and enzyme-linked immunosorbent assay (ELISA). His advanced skills in flow cytometry further contribute to his capabilities in clinical biomarker analysis.
Experience with Contract Research Organizations
Christopher Dupont has extensive experience in managing Contract Research Organizations (CROs) for clinical biomarker projects. This experience is critical in ensuring the successful execution of clinical trials and the effective analysis of biomarker data, which is essential for advancing therapeutic development.